INFORMAZIONI SU QUESTO EPISODIO
Osteosarcoma Webinar Series: Jeremy Rosenblum, MD from New York Medical College will discuss his work on combinational next generation CAR NK immunotherapy in osteosarcoma.
Immunotherapeutic approaches to treating osteosarcoma have had limited success to date. Using natural killer cells as the base platform, our group seeks to combine immunotherapies to cure osteosarcoma. The presentation will describe projects using chimeric antigen receptor natural killer (CAR-NK) cells together with monoclonal antibodies, as well as a newly funded project modifying CAR-NK cells to be able to overcome the immunosuppressive osteosarcoma tumor microenvironment.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di MIB Agents OsteoBites and osTEAo.
ALTRI EPISODI IN QUESTO PODCAST
Recorded live at FACTOR 2026, this episode of osTEAo features conversations with OsteoWarriors, OsteoSiblings, parents and family members, as well as the behind-the-scenes volunteers and staff who help make FACTOR possible. Guests share their experiences, favorite memories, and what this community …
Metastatic osteosarcoma remains a major clinical challenge, highlighting the need to better understand the molecular mechanisms that drive disease progression. In this talk, Moreno will present the use of an in vivo CRISPR interference (CRISPRi) screen to identify genes that promote osteosarcoma pr…
Dr. Alexander Davies discusses his OutSmarting Osteosarcoma-funded work on the validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis, funded Because of Matthew, in partnership with Fishin' for the Cure.
Osteosarcoma Webinar Series: Dr. Jing Huang is a Senior Investigator and Head of the Cancer and Stem Cell Epigenetics Group in the Laboratory of Cancer Biology and Genetics at the National Cancer Institute (NCI). He received his bachelor’s degree in Biochemistry from Peking University and his Ph.D.…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da MIB Agents Osteosarcoma, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
